A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
Clinical trial NCT02559895 · COMPLETED
Trial details
- NCT number
- NCT02559895
- Sponsor
- Alder Biopharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2017-02-01
- Enrollment
- 898
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.